Masafumi Yamaguchi Selected Research

Masafumi Yamaguchi Research Topics

Disease

37	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2002
25	Neoplasms (Cancer) 05/2022 - 01/2002
14	Lung Neoplasms (Lung Cancer) 12/2021 - 01/2002
13	Asthma (Bronchial Asthma) 01/2017 - 03/2006
9	Adenocarcinoma 04/2020 - 05/2002
7	Adenocarcinoma of Lung 01/2021 - 09/2013
6	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2003
5	Malignant Mesothelioma 01/2017 - 05/2004
5	Cough 03/2012 - 04/2007
4	Inflammation (Inflammations) 04/2020 - 03/2008
4	Cough-Variant Asthma 01/2012 - 03/2006
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2021 - 04/2015
3	Disease Progression 06/2021 - 10/2014
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 05/2002
3	Thymoma (Thymic Carcinoma) 04/2016 - 10/2013
3	Chronic Cough 01/2011 - 03/2009
3	Respiratory Sounds (Crackle) 03/2009 - 03/2006
2	Pneumonia (Pneumonitis) 05/2022 - 06/2021
2	Lymphatic Metastasis 03/2021 - 04/2018
2	Pain (Aches) 01/2020 - 06/2007
2	Pleural Effusion (Pleural Effusions) 12/2017 - 03/2014
2	Neoplasm Micrometastasis 11/2014 - 01/2002
2	Respiratory Hypersensitivity 01/2012 - 01/2011
1	Blister (Bulla) 06/2021
1	Headache (Headaches) 01/2021
1	Pulmonary Embolism 06/2020
1	Small Cell Carcinoma 04/2020
1	Fever (Fevers) 03/2020
1	Meningitis 03/2020
1	Encephalitis (Encephalitis, Rasmussen) 03/2020
1	Aseptic Meningitis 03/2020
1	Consciousness Disorders 03/2020
1	Acute Generalized Exanthematous Pustulosis 01/2020
1	Hip Osteoarthritis (Coxarthrosis) 01/2020
1	Esophageal Neoplasms (Esophageal Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

9	Immune Checkpoint InhibitorsIBA 05/2022 - 04/2020
8	ErbB Receptors (EGF Receptor)IBA 11/2020 - 09/2013
6	Cisplatin (Platino)FDA LinkGeneric 04/2020 - 01/2006
5	pembrolizumabIBA 05/2022 - 09/2019
5	PlatinumIBA 12/2021 - 10/2013
5	Methacholine Chloride (Methacholine)FDA Link 03/2012 - 11/2006
4	Gemcitabine FDA Link 12/2021 - 05/2010
4	Tyrosine Kinase InhibitorsIBA 06/2021 - 03/2015
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2006
4	B7-H1 AntigenIBA 01/2021 - 04/2020
4	Anaplastic Lymphoma KinaseIBA 01/2020 - 09/2013
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2010 - 03/2006
3	LigandsIBA 06/2021 - 01/2021
3	Pharmaceutical PreparationsIBA 06/2021 - 11/2011
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2011
3	Vinorelbine (Navelbine)FDA LinkGeneric 03/2020 - 02/2014
3	AllergensIBA 03/2012 - 10/2007
3	Capsaicin (Zostrix)FDA Link 01/2012 - 04/2007
2	TegafurIBA 12/2021 - 11/2013
2	AlbuminsIBA 06/2021 - 01/2021
2	C-Reactive ProteinIBA 06/2021 - 01/2021
2	amrubicinIBA 04/2020 - 10/2013
2	atezolizumabIBA 04/2020 - 03/2020
2	CrizotinibIBA 01/2020 - 11/2013
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2017 - 05/2014
2	ProstaglandinsIBA 01/2017 - 01/2012
2	Pemetrexed (MTA)FDA Link 06/2015 - 08/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2015 - 03/2014
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 07/2014 - 09/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2012 - 01/2011
2	Bronchodilator Agents (Bronchodilators)IBA 01/2012 - 03/2009
2	MucinsIBA 09/2011 - 05/2010
2	Saline SolutionIBA 01/2006 - 06/2004
1	NivolumabIBA 05/2022
1	UracilIBA 12/2021
1	osimertinibIBA 07/2021
1	Nucleic AcidsIBA 07/2021
1	Cell-Free Nucleic AcidsIBA 07/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	durvalumabIBA 01/2021
1	AntibodiesIBA 01/2021
1	tepotinibIBA 01/2021
1	lorlatinibIBA 06/2020
1	Tumor Biomarkers (Tumor Markers)IBA 04/2020
1	Phosphopyruvate Hydratase (Enolase)IBA 04/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2020
1	Carboplatin (JM8)FDA LinkGeneric 03/2020
1	Docetaxel (Taxotere)FDA Link 03/2020
1	Monoclonal AntibodiesIBA 09/2019
1	AfatinibIBA 04/2018
1	Dinoprostone (PGE2)FDA Link 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 04/2016

Therapy/Procedure

20	Therapeutics 12/2021 - 02/2003
16	Drug Therapy (Chemotherapy) 12/2021 - 05/2004
10	Radiotherapy 12/2021 - 05/2004
8	Chemoradiotherapy 01/2021 - 10/2002
7	Pneumonectomy (Lung Volume Reduction) 03/2019 - 05/2004
4	Adjuvant Chemotherapy 03/2021 - 05/2010
3	Segmental Mastectomy (Lumpectomy) 01/2022 - 06/2002
3	Aftercare (After-Treatment) 12/2021 - 01/2012
3	Lymph Node Excision (Lymph Node Dissection) 12/2017 - 03/2010
2	Combined Modality Therapy 03/2021 - 05/2004
2	Immunotherapy 12/2020 - 04/2020
2	Sternotomy 01/2011 - 02/2006
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2020